自然周期监测排卵 中国就医指南

Natural Cycle Ovulation Monitoring (NCOM) is not a disease but a non-invasive, fertility-sparing clinical strategy used in reproductive medicine to track spontaneous ovulation without exogenous hormonal stimulation. It serves as both a diagnostic tool and a foundational protocol for timed intercourse or intrauterine insemination (IUI) in women with regular menstrual cycles and confirmed ovulatory function. NCOM relies on serial transvaginal ultrasound assessments—typically starting on cycle day 9–11—to monitor follicular growth, endometrial thickness, and ovulation timing, supplemented by urinary luteinizing hormone (LH) surge testing and serum estradiol/progesterone measurements when indicated. Pathophysiologically, its application hinges on intact hypothalamic-pituitary-ovarian (HPO) axis regulation; thus, it is contraindicated in anovulatory disorders (e.g., PCOS, hypothalamic amenorrhea), premature ovarian insufficiency, or significant endometrial pathology. Epidemiologically, NCOM is most frequently utilized in couples with unexplained infertility (affecting ~15–30% of infertile couples globally) or mild male factor infertility, particularly among women aged 25–35 years seeking low-intervention conception pathways. Risk factors limiting its efficacy include irregular cycle length (>35 days or <21 days), inconsistent LH surge detection, suboptimal follicular development (<16 mm), thin endometrium (<7 mm), or coexisting tubal obstruction or severe sperm abnormalities. Unlike pharmacologic ovulation induction, NCOM carries no risk of ovarian hyperstimulation syndrome (OHSS) or multiple gestation—but success rates per cycle remain modest (10–20% clinical pregnancy rate), necessitating repeated cycles and potentially prolonging time-to-pregnancy. Psychosocially, the process can induce significant stress due to its time-intensive nature (frequent clinic visits, strict timing demands), uncertainty around ovulation prediction, and emotional vulnerability during the two-week wait. Patients often report diminished quality of life during active monitoring—characterized by anxiety, disrupted work-life balance, sexual pressure around fertile windows, and frustration with inconclusive or delayed outcomes. Nevertheless, many value its safety profile, autonomy, absence of medication side effects, and alignment with holistic or integrative fertility approaches. NCOM is especially appropriate for patients prioritizing natural conception, those with contraindications to gonadotropins or clomiphene, or as a first-line assessment before escalating to assisted reproductive technologies (ART). Its role continues to evolve within personalized fertility care, increasingly integrated with AI-assisted ultrasound analytics and digital LH tracking platforms to improve predictive accuracy and reduce burden.

# 自然周期监测排卵（生殖医学科）治疗方案与费用明细

一、非手术/保守治疗方案

适用于月经规律、基础激素正常、无器质性病变的备孕女性。

• •超声动态监测（含卵泡发育评估）：共3–5次经阴道超声，800–1,500元（含挂号费、超声费、报告解读）
• •基础性激素六项（月经第2–5天）：320–450元
• •黄体中期孕酮检测（排卵后7天）：120–180元
• •尿LH试纸指导同房（自购）：50–200元/周期

二、药物辅助监测方案（需医嘱）

适用于卵泡发育迟缓或LH峰不显者。

• •来曲唑促排+超声监测（1周期）：药费120元 + 监测费1,000–1,600元 = 1,120–1,720元
• •HCG触发+黄体支持（地屈孕酮）：药费+监测费合计 1,300–2,000元

三、手术/介入方案（极少适用）

自然周期监测本身不涉及手术；仅当合并输卵管积水、子宫内膜息肉等需干预时启动，属独立诊疗项目，不纳入本方案费用范畴。

四、复杂情况处理

反复监测无排卵、高龄（≥38岁）、PCOS合并胰岛素抵抗者：升级为“改良自然周期”或转人工周期，费用升至 2,200–3,500元/周期（含胰岛素抵抗评估、AMH、甲状腺全套等附加检查）。

五、方案快速选择指南

• •预算≤1,500元/周期：首选纯超声监测+性激素基础筛查
• •追求精准时机+中等预算（1,500–2,000元）：来曲唑联合监测
• •反复失败或高龄：建议转入个体化促排卵方案，同步排查卵巢储备及代谢因素